| Patient Death in Poseida Prostate Cancer Study Prompts Clinical Hold | Sarah de Crescenzo | 08/18/20 | San Diego |
| GlaxoSmithKline Multiple Myeloma Drug Earns FDA’s First Anti-BCMA Nod | Sarah de Crescenzo | 08/06/20 | National |
| Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More | Frank Vinluan | 07/17/20 | National |
| 3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments | Sarah de Crescenzo | 07/13/20 | National |
| Bio Roundup: Blackstone’s Billions, Biogen Finishes Filing, Novavax at “Warp Speed” & More | Sarah de Crescenzo | 07/10/20 | National |
| Bio Roundup: Gilead’s Pionyr Grab, Relay to IPO, Unicorn Sana & More | Sarah de Crescenzo | 06/26/20 | National |
| BCMA Delay: FDA Refuses Review of Bristol Drug, Asks for More Info | Frank Vinluan | 05/13/20 | New York |
| San Diego Roundup: Qualcomm, Philter, Stella Labs, VC Funding & More | Sarah de Crescenzo | 07/19/19 | San Diego |
| Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More | Frank Vinluan | 04/26/19 | National |
| Poseida to Advance CAR-T For Myeloma with Novartis-Led $142M Round | Sarah de Crescenzo | 04/22/19 | San Diego |
| Government Shutdown Hits Biotech as FDA Punts Review of Aimmune Drug | Ben Fidler | 01/15/19 | San Francisco |
| Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More | Frank Vinluan | 01/11/19 | National |
| BCMA Day: At ASH ‘18, Cell Therapies For Myeloma Take Center Stage | Ben Fidler | 12/04/18 | National |
| With a New Name, Afyx Aims to Improve Oral Disease Treatment | Sarah de Crescenzo | 09/27/18 | San Diego |
| AACR Review: Biden Fired Up, Incyte Doubles Up, BMS Up And Down | Alex Lash | 04/06/17 | National |
